Axon price target raised to $400 from $315 at Needham

Needham analyst Joshua Reilly raised the firm’s price target on Axon to $400 from $315 and keeps a Buy rating on the shares. The firm is citing its updated total addressable market model that incorporates the underlying assumptions of the company’s market opportunity. The primary change to the update is the inclusion of Fusus, which offers a real-time crime center with integrated video feeds to more accurately assess the current threat landscape, the analyst tells investors in a research note.